{"agency": "Federal Trade Commission", "agency_short": "FTC", "published": "2012-08-08T12:00:00+00:00", "title": "Generic Pharmaceutical Association", "url": "https://www.ftc.gov/legal-library/browse/advisory-opinions/generic-pharmaceutical-association", "attachments": [{"title": "Letter From Markus H. Meier, Assistant Director, Health Care Division, Bureau of Competition, to E. John Steren, Ober, Kaler, Grimes & Shriver, Concerning the Generic Pharmaceutical Association's Proposed Initiative to Address Drug Shortages, dated August 8, 2012", "url": "https://www.ftc.gov/sites/default/files/documents/advisory-opinions/generic-pharmaceutical-association/120808gphaopinion.pdf", "mimetype": "application/pdf"}, {"title": "Incoming Letter from the Generic Pharmaceutical Association, Inc., dated July 16, 2012 [Public Record Version]", "url": "https://www.ftc.gov/sites/default/files/documents/advisory-opinions/generic-pharmaceutical-association/120810gphapublicrecordletter.pdf", "mimetype": "application/pdf"}], "classification": "advisory-opinion", "identifier": "FTC-63f6e839cf0cd9896d4afce2f72679a490ee46e8f202a53254ec8e31ed95243a", "subagency": "", "summary": ""}